ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANT RECIPIENT
Clinical trials for ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANT RECIPIENT explained in plain language.
Never miss a new study
Get alerted when new ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANT RECIPIENT trials appear
Sign up with your email to follow new studies for ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANT RECIPIENT, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Can a vaccine shield transplant patients from HPV?
⭐️ VACCINE ⭐️ OngoingThis study looks at whether the Gardasil 9 vaccine can help prevent HPV infection in people who have had a stem cell transplant for blood cancer. About 48 adults will receive the vaccine as part of their usual post-transplant care. Researchers will measure antibody levels to see …
Matched conditions: ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANT RECIPIENT
Phase: PHASE4 • Sponsor: M.D. Anderson Cancer Center • Aim: ⭐️ VACCINE ⭐️
Last updated May 17, 2026 04:16 UTC
-
Can genetically engineered goat milk stop a deadly transplant side effect?
Disease control TerminatedThis early-stage trial tests whether drinking milk from goats genetically modified to produce a human enzyme (lysozyme) can help prevent graft-versus-host disease (GVHD) in people with blood cancer receiving a donor stem cell transplant. About 53 participants will drink a daily a…
Matched conditions: ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANT RECIPIENT
Phase: PHASE1 • Sponsor: City of Hope Medical Center • Aim: Disease control
Last updated May 17, 2026 04:09 UTC